Similar articles

• Depression among dialysis patients: barriers to good care.

  Farrokhi F. Farrokhi F. Iran J Kidney Dis. 2012 Nov;6(6):403-6. Iran J Kidney Dis. 2012. PMID: 23146976 No abstract available.
• Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients.

  Hosseini SH, Espahbodi F, Mirzadeh Goudarzi SM. Hosseini SH, et al. Iran J Kidney Dis. 2012 Nov;6(6):446-51. Iran J Kidney Dis. 2012. PMID: 23146983 Clinical Trial.
• What are the optimal treatment courses for geriatric anxiety, and how do we find out?

  Barlow DH, Comer JS. Barlow DH, et al. Am J Psychiatry. 2013 Jul;170(7):707-11. doi: 10.1176/appi.ajp.2013.13040513. Am J Psychiatry. 2013. PMID: 23680970 No abstract available.
• Escitalopram: a review of its use in the management of anxiety disorders.

  Dhillon S, Scott LJ, Plosker GL. Dhillon S, et al. CNS Drugs. 2006;20(9):763-90. doi: 10.2165/00023210-200620090-00010. CNS Drugs. 2006. PMID: 16953656 Review.
• [Escitalopram: a chiral agent for treatment of depression].

  Overlack M, Davids E, Gastpar M. Overlack M, et al. Med Monatsschr Pharm. 2004 May;27(5):148-51. Med Monatsschr Pharm. 2004. PMID: 15171592 Review. German. No abstract available.